BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following research. If you own stock and would like to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. You will not incur any costs or financial obligations.

Iveric Bio Inc. (Nasdaq – ISEE)

Under the terms of the merger agreement, Iveric Bio will be acquired by Astellas Pharma Inc. (“Astellas”). Iveric Bio shareholders will receive $40.00 in cash for each Iveric Bio share they own, for a total NPV of approximately $5.9 billion if Astellas underpays the company.

For more information, see https://www.brodskysmith.com/cases/iveric-bio-inc-nasdaq-isee/.

Midwest Holdings Inc. (Nasdaq – MDWT)

Under the terms of the merger agreement, Midwest Holding will be acquired by Antarctica Capital (“Antarctica”). Midwest Holding stockholders will receive $27.00 in cash for each Midwest Holding share they own. The investigation concerns whether the Midwest Holding board of directors breached its fiduciary duties to shareholders by failing to conduct a fair trial, including whether Antarctica underpaid the company.

For more information, see https://www.brodskysmith.com/cases/midwest-holding-inc-nasdaq-mdwt/.

Hoth Therapeutics, Inc. (Nasdaq – HOTH)

Under the terms of the Agreement, Hoth will be acquired by Algorithm Sciences, Inc. (“Algorithm”). On a pro forma basis and based on the number of Hoth common shares to be issued pursuant to the merger, current Hoth shareholders are expected to currently own approximately 14% of the combined company and current Algorithm shareholders are expected to own approximately 86% of the combined company. The subject of the investigation is whether the…